List view / Grid view
1 December 2015 | By Victoria White
The team from the Broad Institute and the McGovern Institute for Brain Research found that mutations in three amino acids dramatically reduced “off-target” cuts...
30 November 2015 | By Victoria White
Heptares and Pfizer have announced they are to research and develop potential new medicines directed at up to 10 G protein-coupled receptor (GPCR) targets across multiple therapeutic areas...
30 November 2015 | By Victoria White
The aim of the project is to design a drug to inhibit a key parasite enzyme involved in the conversion of blood sugars to energy, to be effective in small doses, even on advanced infections, and kill the parasite...
27 November 2015 | By Victoria White
Researchers have discovered how connections between brain cells are destroyed in the early stages of Alzheimer’s disease...
27 November 2015 | By
Pelago and AstraZeneca will together develop assay formats and applications of the CETSA method relevant across the range of AstraZeneca’s therapeutic areas...
25 November 2015 | By Victoria White
The transaction, expected to complete next month, is aimed at strengthening ReproCELL’s pharmaceutical industry-targeted drug discovery services...
25 November 2015 | By
Ablynx and Novo Nordisk hope to discover and develop novel multi-specific drug candidates using Ablynx's proprietary Nanobody technology...
24 November 2015 | By Victoria White
Pneumolysin is associated with deadly infections such as bacterial pneumonia, meningitis and septicaemia...
22 November 2015 | By Illumina
In this webinar, we focus on the use of microarray technology in drug development...
20 November 2015 | By Victoria White
The company has announced three new partnerships that will deliver a collaborative screening platform, space-age robotics, and sound waves that can move liquids...
20 November 2015 | By Victoria White
The technology has already been successfully tested in the laboratory. If it works in patients, the therapy could one day revolutionise treatment for many forms of cancer...
18 November 2015 | By Victoria White
DBV Tecnologies observed an immunogenic response in mice and swine treated with Viaskin with a patented formulation containing an N-FsII antigen...
16 November 2015 | By Victoria White
Researchers have created molecules that mimic and dominate toxic ones secreted by bacteria. The implications for the study of biology and pharmacology are said to be enormous...
11 November 2015 | By Victoria White
Of the total investment, EUR 5 billion will go to preclinical R&D with EUR 1.5 billion thereof planned for collaborations with external partners...
11 November 2015 | By Victoria White
Preclinical studies confirm the efficacy of Anisina when delivered using a clinically relevant formulation, mode of administration and dosing regimen...
